SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-291679
Filing Date
2020-11-12
Accepted
2020-11-12 16:16:01
Documents
18
Period of Report
2020-12-15
Effectiveness Date
2020-11-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d79683ddef14a.htm DEF 14A 786486
2 GRAPHIC g79683dsp078.jpg GRAPHIC 2784
3 GRAPHIC g79683dsp152a.jpg GRAPHIC 1733
4 GRAPHIC g79683dsp152b.jpg GRAPHIC 1765
5 GRAPHIC g79683dsp152cc.jpg GRAPHIC 20100
6 GRAPHIC g79683g07h69.jpg GRAPHIC 24155
7 GRAPHIC g79683g25n11.jpg GRAPHIC 53293
8 GRAPHIC g79683g35h24.jpg GRAPHIC 21597
9 GRAPHIC g79683g71c37.jpg GRAPHIC 23765
10 GRAPHIC g79683g71u63.jpg GRAPHIC 21836
11 GRAPHIC g79683g99d89.jpg GRAPHIC 82695
12 GRAPHIC g79683snap0004.jpg GRAPHIC 2301
13 GRAPHIC g79683snap0005.jpg GRAPHIC 1070
14 GRAPHIC g79683snap0006.jpg GRAPHIC 1398
15 GRAPHIC g79683snap0007.jpg GRAPHIC 1082
16 GRAPHIC g79683snap0008.jpg GRAPHIC 2918
17 GRAPHIC g79683snap0012.jpg GRAPHIC 17569
18 GRAPHIC g79683snap0013.jpg GRAPHIC 14767
  Complete submission text file 0001193125-20-291679.txt   1176983
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 201306897
SIC: 2834 Pharmaceutical Preparations